Nuwellis, Inc. (NUWE) · Oct 23, 2026 · Rights change
1-for-9 reverse split — Effective October 26; split-adjusted trading begins October 27
Nuwellis’ reverse split takes effect October 26, with split-adjusted trading October 27. It supports listing compliance but changes no business fundamentals.
Nuwellis is a commercial-stage medical-device company focused on building adoption and recurring consumables revenue around its Aquadex ultrafiltration system. Recent 2026 updates highlighted double-digit revenue growth and expanding console adoption, but the company has also relied on repeated reverse splits and financing activity to support its Nasdaq listing and capital position.
This filing formalizes another listing-maintenance action, not an operating milestone. The board selected a 1-for-9 consolidation after shareholders had already authorized a range of 1-for-5 to 1-for-70. 〔0〕 The move mechanically reduces the share count and proportionally adjusts preferred-stock conversions, options, restricted stock units and warrants; it does not add cash or improve Aquadex demand. 〔1〕
The immediate objective is to reset the trading price and preserve Nasdaq access. The split becomes effective at 5:00 p.m. Eastern Time on October 26, 2026, with split-adjusted trading beginning October 27. 〔2〕 Because the authorization, the broad ratio range and the need to address listing requirements were already public, the new information is mainly the exact 1-for-9 ratio and implementation date.
The business read-through is limited and two-sided. Completing the split helps keep the company’s listed-market infrastructure in place, but the fact that Nuwellis is executing another reverse split only months after its 1-for-35 split underscores ongoing capital-markets pressure rather than progress in the underlying medical-device business.
Bottom line: This is a structural reset to support Nasdaq trading, not a change to Nuwellis’ operating trajectory. It matters for listing continuity, but it leaves the Aquadex business and funding challenge essentially unchanged.
Split-adjusted trading begins October 27
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!